BioSpace News Archive

Existing investors also participated in the round to further Magenta’s development of miniaturized pumps to treat heart failure patients

Axonics Modulation Technologies, Inc. a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation devices for the treatment of urinary and bowel dysfunction, announced the results from its ARTISAN-SNM study were published online in the peer-reviewed Journal of Urology.

Don Haut, Ph.D., as chief business officer, and William J. Blake, Ph.D., as chief technology officer.

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for patent application 15/561,915.

Today HR Pharmaceuticals is proud to announce Maness Veteran Medical, LLC, as its official SDVOSB.

Digipath, Inc. (OTCQB: DIGP) (“DIGP” or the “Company”), a service-oriented independent testing laboratory, data analytics and formulation firm focused on the developing cannabis and hemp markets, is pleased to announce that the Company’s GroSciences subsidiary has made significant progress in developing its Tru-Hemp ID project, with commercial availability targeted for late 2019/early 2020

The WIRB-Copernicus Group®'s (WCG™) Clinical Services Division will offer its unique data-driven benchmarking solution to companies that discover and develop vaccines, helping them to increase productivity, reduce cycle-times, and maximize their investment in research and development.

With more than 40 years in the pharmaceutical industry, Peroxfarma announced earlier this year that it would roll-out a wide array of nutritional supplements

NEC Corporation announced the acquisition of OncoImmunity AS, a Norway-based bioinformatics company that develops proprietary machine learning software to support the fight against cancer.

The first quarter results press release will be issued on August 14, 2019 before the conference call.